Surgery for hepatocellular carcinoma


Dr KC Tan, Gleneagles Medical Centre, 6 Napier Road, Suite #04-14/15, Singapore 258499. Email:


Abstract  Today there is an array of therapeutic modalities available for the patients with hepatocellular carcinoma (HCC). However, surgery, be it resection or transplantation, offers the only hope of long-term disease-free survival. Unfortunately, because the majority of HCC in Asia is associated with cirrhosis, surgical resection is restricted to only a small proportion of these patients. However, in selected candidates resection may offer a 5-year survival of up to 70%. With the clinical application of adult-to-adult living donor liver transplantation, an increasing number of patients with small HCC and decompensating cirrhosis are undergoing transplantation.

© 2002 Blackwell Publishing Asia Pty Ltd